Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG). Επικοινωνία Submitted by Δημήτρης Σπάχος on Δευ, 05/04/2015 - 10:33
